Biomaterials 2022

Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devices

Chronic infection as a result of bacterial biofilm formation on implanted medical devices is a major global healthcare problem requiring new biocompatible, biofilm-resistant materials. Here we demonstrate how bespoke devices can be manufactured through ink-jet-based 3D printing using bacterial biofilm inhibiting formulations without the need for eluting antibiotics or coatings. Candidate monomers were formulated and their processability and reliability demonstrated. Formulations for in vivo evaluation of the 3D printed structures were selected on the basis of their in vitro bacterial biofilm inhibitory properties and lack of mammalian cell cytotoxicity. In vivo in a mouse implant infection model, Pseudomonas aeruginosa biofilm formation on poly-TCDMDA was reduced by ∼99% when compared with medical grade silicone. Whole mouse bioluminescence imaging and tissue immunohistochemistry revealed the ability of the printed device to modulate host immune responses as well as preventing biofilm formation on the device and infection of the surrounding tissues. Since 3D printing can be used to manufacture devices for both prototyping and clinical use, the versatility of ink-jet based 3D-printing to create personalised functional medical devices is demonstrated by the biofilm resistance of both a finger joint prosthetic and a prostatic stent printed in poly-TCDMDA towards P. aeruginosa and Staphylococcus aureus.

The full article can be read in the journal Biomaterials.

Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devices
Yinfeng He, Jeni Luckett, Belen Begines, Jean-Frederic Dubern, Andrew L. Hook, Elisabetta Prina, Felicity R.A.J. Rose, Christopher J. Tuck, Richard J.M. Hague, Derek J. Irvine, Paul Williams, Morgan R. Alexander & Ricky D. Wildman
Biomaterials Volume 281, February 2022, 121350
https://doi.org/10.1016/j.biomaterials.2021.121350